Discover how artificial intelligence is transforming metabolomics—from smart experimental design to advanced data analysis and multi-omics integration.
Discover how gut bacteria impact Parkinson’s disease through neuroinflammation and short-chain fatty acids, revealed by untargeted metabolomics in a groundbreaking study.
See examples of how we collaborate with partners to advance research and product development. Our project experience spans preclinical trials, clinical interventions, formulation studies, and more.
